HHS Senior Advisor O’Brien Emerges As Azar’s Lead On Drug Pricing In 2019

O’Brien assumes role from his late colleague and friend Dan Best as HHS closes out administrative items in the blueprint.

RollOfDollarswithPills_1200x675

More from Pricing Debate

More from Market Access